Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Unchanged | 2024-09-30 | 13G | Q32 Bio Inc. QTTB | 5AM Ventures IV L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:25 pm Sale | 2023-12-31 | 13G | scPharmaceuticals Inc. SCPH | 5AM Ventures IV L.P. | 1,200,647 3.300% | -1,534,205 (-56.10%) | Filing History |
| 2023-04-12 4:33 pm Unchanged | 2023-04-10 | 13D | PEAR THERAPEUTICS INC PEARQ | 5AM Ventures IV L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:04 pm Sale | 2022-12-31 | 13G | scPharmaceuticals Inc. SCPH | 5AM Ventures IV L.P. | 2,734,852 8.000% | -1,096,622 (-28.62%) | Filing History |
| 2022-09-16 5:09 pm Sale | 2022-09-14 | 13D | Pear Therapeutics, Inc. PEAR | 5AM Ventures IV L.P. | 16,903,954 12.200% | -1,727,817 (-9.27%) | Filing History |
| 2021-12-13 4:16 pm Purchase | 2021-12-03 | 13D | Pear Therapeutics, Inc. PEAR | 5AM Ventures IV L.P. | 18,631,771 13.500% | 18,631,771 (New Position) | Filing History |
| 2021-08-11 4:31 pm Sale | 2021-08-04 | 13D | IDEAYA Biosciences, Inc. IDYA | 5AM Ventures IV L.P. | 1,398,066 3.700% | -408,650 (-22.62%) | Filing History |